NNNN (Anbio Biotechnology Class A Ordinary Shares) Stock Analysis - SEC Filings

Anbio Biotechnology Class A Ordinary Shares (NNNN) is a publicly traded Healthcare sector company. As of May 21, 2026, NNNN trades at $31.00 with a market cap of $1.24B and a P/E ratio of 0.00. NNNN moved +2.57% today. Year to date, NNNN is -6.90%; over the trailing twelve months it is +298.00%. Its 52-week range spans $5.18 to $55.65. Rallies surfaces NNNN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find NNNN SEC filings?

Rallies organizes NNNN SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

NNNN Key Metrics

Key financial metrics for NNNN
MetricValue
Price$31.00
Market Cap$1.24B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$55.65
52-Week Low$5.18
Volume110
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest NNNN News

NNNN Analyst Consensus

NNNN analyst coverage data. Average price target: $0.00.

Common questions about NNNN

Where can I find NNNN SEC filings?
Rallies organizes NNNN SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show NNNN 10-K and 10-Q filings?
Rallies organizes NNNN SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is NNNN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NNNN. It does not provide personalized investment advice.
NNNN

NNNN